VISCERAL FAT ACCUMULATION INHIBITOR

摘要

Disclosed is a pharmaceutical or beverage/food which can reduce the fat accumulated in the abdominal cavity and can prevent or ameliorate visceral obesity which is believed to be the primary cause of metabolic syndrome. The pharmaceutical or beverage/food comprises, as an active ingredient, 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol, or an extract of a plant belonging to the family Liliaceae with an organic solvent or hot water, a squeezed product of the plant or a fractionated product of the extract or squeezed product which contains the compound.